Repligen Corporation (RGEN)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	41,577	115,794	138,027	167,824	185,959	166,340	159,433	145,805	128,291	118,879	99,933	79,561	59,926	43,832	30,939	23,173	21,411	23,445	26,580	21,223
Total stockholders’ equity	US$ in thousands	1,971,200	1,988,560	1,970,930	1,940,490	1,910,700	1,835,110	1,805,360	1,766,400	1,750,070	1,715,260	1,603,070	1,556,220	1,529,150	1,124,870	1,100,030	1,069,760	1,059,770	1,045,120	878,968	625,025
ROE		2.11%	5.82%	7.00%	8.65%	9.73%	9.06%	8.83%	8.25%	7.33%	6.93%	6.23%	5.11%	3.92%	3.90%	2.81%	2.17%	2.02%	2.24%	3.02%	3.40%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $41,577K ÷ $1,971,200K
= 2.11%

Repligen Corp.'s return on equity (ROE) has shown some fluctuations over the past eight quarters. The ROE ranged from a low of 2.11% in Q4 2023 to a high of 9.73% in Q4 2022. The downward trend in ROE from Q4 2022 to Q4 2023 indicates a decline in the company's ability to generate profit from shareholder equity during this period. The decreasing trend suggests that the company may be experiencing challenges in efficiently utilizing its equity to generate profits, which could raise concerns about its overall financial performance. The management should closely monitor and assess the factors contributing to this trend and take appropriate measures to improve the ROE in the future quarters.